The federal government needs to make it an urgent priority to provide increased and predictable funding for health and biosciences research, or risk losing the nation’s health research workforce to competing countries like the U.S., the U.K. and Australia, says Paul-Émile Cloutier, president and CEO of HealthCareCAN, in an op-ed.
Person: François-Philippe Champagne
The U.S.-based vaccine manufacturer Moderna Inc. will be building a plant in Canada after signing a memorandum of understanding with the Canadian government this week.
The federal government has released a list of guidelines for universities and research institutions as the result of a working group convened earlier this summer.
China’s investments in and with Canadian universities and companies pose a serious risk to Canada’s security, personal data, research and technology, says Margaret McCuaig-Johnston, a senior fellow at the Institute for Science, Society and Policy at the University of Ottawa, and former executive vice-president of NSERC.
The Clean Resource Innovation Network (CRIN) is making up to $80 million in federal funding available through oil and gas industry challenges to accelerate the development and commercialization of clean technology.
When Budget 2021 drops on April 19, some of Canada’s quantum researchers and entrepreneurs will be holding their breath. That is because the Standing Committee on Finance published a budget recommendation in February urging the federal government to “financially support the establishment of a quantum computing research institute in the Toronto area, similar to the Vector Institute.”
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.
New plant expected to produce 240 million vaccine doses every year starting in 2023.
Prime Minister Justin Trudeau is much more focused on his government’s response to COVID-19 than on science and innovation priorities, judging by the PM’s updated mandate letter to the minister of innovation. The letter mentions the world “innovation” once, compared with more than a half-dozen references to COVID-19 and the federal response to the pandemic